Catalyst
Slingshot members are tracking this event:
Allergan (AGN) to complete Phase 3 study of of Vilazodone in Adolescent Patients With Major Depressive Disorder in summer 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AGN |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 06, 2016
Occurred Source:
https://clinicaltrials.gov/archive/NCT01878292/2016_10_06/changes
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Study, Vilazodone, Major Depressive Disorder, Viibryd
